Imigran Radis Filmuhúðuð tafla 100 mg আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

imigran radis filmuhúðuð tafla 100 mg

glaxosmithkline pharma a/s - sumatriptanum súkkínat - filmuhúðuð tafla - 100 mg

Imigran Radis Filmuhúðuð tafla 50 mg আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

imigran radis filmuhúðuð tafla 50 mg

glaxosmithkline pharma a/s - sumatriptanum súkkínat - filmuhúðuð tafla - 50 mg

Imigran Nefúði, lausn 20 mg/skammt আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

imigran nefúði, lausn 20 mg/skammt

glaxosmithkline pharma a/s - sumatriptanum inn - nefúði, lausn - 20 mg/skammt

Imigran Stungulyf, lausn 12 mg/ml আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

imigran stungulyf, lausn 12 mg/ml

glaxosmithkline pharma a/s - sumatriptanum súkkínat - stungulyf, lausn - 12 mg/ml

Aimovig ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

aimovig

novartis europharm limited - erenumab - mígreni kvilla - verkjalyf - aimovig er ætlað til að fyrirbyggja mígreni í fullorðnir sem hafa minnsta kosti 4 mígreni daga á mánuði þegar hefja meðferð með aimovig.

Emgality ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

emgality

eli lilly nederland b.v. - galcanezumab - mígreni kvilla - analgesics, galcanezumab - emgality er ætlað til að fyrirbyggja mígreni í fullorðnir sem hafa minnsta kosti 4 mígreni daga á mánuði.

Ajovy ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

ajovy

teva gmbh - fremanezumab - mígreni kvilla - calcitonin gene-related peptide (cgrp) antagonists - ajovy er ætlað til að fyrirbyggja mígreni í fullorðnir sem hafa minnsta kosti 4 mígreni daga á mánuði.

Aquipta ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

aquipta

abbvie deutschland gmbh & co. kg - atogepant - mígreni kvilla - aquipta is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.

Vyepti ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

vyepti

h. lundbeck a/s - eptinezumab - mígreni kvilla - verkjalyf - vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.

Vydura ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

vydura

pfizer europe ma eeig  - rimegepant - mígreni kvilla - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.